BREAKING NEWS

BREAKING NEWS

Former GSK CEO and ex-R&D boss move to biotech venture firms

Now Reading:

Former GSK CEO and ex-R&D boss move to biotech venture firms

Text size Aa Aa

LONDON (Reuters) – GlaxoSmithKline’s <GSK.L> former chief executive Andrew Witty and its one-time research head Moncef Slaoui both picked up new jobs in the biotech venture capital sector on Tuesday, following a route favoured by many ex-pharma executives. Witty, who stepped down as head of Britain’s biggest drugmaker in March, is joining U.S.-based Hatteras Venture Partners, while Slaoui has signed up with European venture firm Medicxi, the companies said in separate statements. At Hatteras, Witty will be working with general partner Bob Ingram, another former CEO of Glaxo.

(Reporting by Ben Hirschler, editing by Louise Heavens)
euronews provides breaking news articles from reuters as a service to its readers, but does not edit the articles it publishes. Articles appear on euronews.com for a limited time.